RESEARCH: CANCER
FOLDING PROJECT #16949 PROFILE

This project relates to studying how small protein pieces called hairpins fold and how changes to their structure affect how they work. By understanding this, scientists hope to design better cancer drugs that latch onto specific cells.

These simulations are designed to test our understanding the folding mechanism of alpha-helical hairpins.

We are trying to study how disulfide cross-linkers and sequence variants affect the folding thermodynamics and kinetics of these proteins, to learn how we might better use molecular simulation methods to design effective protein binder scaffolds, for use as "affibody" cancer therapeutics, for example.

alpha-helical hairpins

A type of protein secondary structure characterized by a helical shape.

Alpha-helical hairpins are common structures found in proteins. They are made up of alpha helices, which are spiral-shaped regions of the protein chain. Hairpins have two alpha helices connected by a short loop, resembling a hairpin. These structures play important roles in protein function and stability.

disulfide cross-linkers

Covalent bonds formed between two cysteine amino acids in a protein.

Disulfide cross-linkers are strong covalent bonds that connect two cysteine amino acids within a protein. These bonds help stabilize the protein's three-dimensional structure and can influence its function. Researchers often manipulate disulfide bonds to study protein folding, stability, and interactions.

sequence variants

Variations in the DNA sequence of a gene.

Sequence variants are changes in the order of nucleotides (A, T, C, G) within a gene. These variations can lead to different protein versions and affect various biological processes. Understanding sequence variants is crucial for studying genetic diseases, personalized medicine, and drug development.

folding thermodynamics

The study of energy changes associated with protein folding.

Folding thermodynamics investigates the energy required and released during protein folding. This field helps understand how proteins adopt their specific three-dimensional shapes and what factors influence stability. Understanding these principles is essential for designing new drugs and therapies.

protein binder scaffolds

Structural frameworks for designing therapeutic proteins that bind to specific targets.

Protein binder scaffolds are foundational structures used to build therapeutic proteins. These scaffolds provide the basic framework for binding to specific target molecules, such as disease-causing proteins. Designing efficient protein binder scaffolds is crucial for developing effective therapies.

affibody

A type of small protein scaffold that binds to specific targets.

Affibody is a compact protein derived from bacterial cell surface proteins. It exhibits high binding affinity and specificity for various targets, making it suitable for developing diagnostic tools and therapeutic agents.

cancer therapeutics

Medications used to treat cancer.

Cancer therapeutics encompass a range of drugs designed to combat the growth and spread of cancer cells. These treatments aim to kill cancer cells, inhibit their proliferation, or prevent tumor formation.